Pharmacokinetics of arsenic trioxide in patients with acute promyelocytic leukemia.

被引：0
|
作者：
Nagy, AJ
Wang, ZG
Maslak, P
Chanel, S
Ho, R
Spriggs, D
Tong, W
Ellison, R
Pandolfi, PP
Warrell, RP
Soignet, SL
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] PolaRx Biopharmaceut Inc, New York, NY USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 1999年 / 47卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：100A / 100A
页数：1
相关论文
共 50 条
  • [41] Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
    Lo-Coco, F.
    Avvisati, G.
    Vignetti, M.
    Thiede, C.
    Orlando, S. M.
    Iacobelli, S.
    Ferrara, F.
    Fazi, P.
    Cicconi, L.
    Di Bona, E.
    Specchia, G.
    Sica, S.
    Divona, M.
    Levis, A.
    Fiedler, W.
    Cerqui, E.
    Breccia, M.
    Fioritoni, G.
    Salih, H. R.
    Cazzola, M.
    Melillo, L.
    Carella, A. M.
    Brandts, C. H.
    Morra, E.
    von Lilienfeld-Toal, M.
    Hertenstein, B.
    Wattad, M.
    Luebbert, M.
    Haenel, M.
    Schmitz, N.
    Link, H.
    Kropp, M. G.
    Rambaldi, A.
    La Nasa, G.
    Luppi, M.
    Ciceri, F.
    Finizio, O.
    Venditti, A.
    Fabbiano, F.
    Doehner, K.
    Sauer, M.
    Ganser, A.
    Amadori, S.
    Mandelli, F.
    Doehner, H.
    Ehninger, G.
    Schlenk, R. F.
    Platzbecker, U.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (02): : 111 - 121
  • [42] Advances in management of acute promyelocytic leukemia with arsenic trioxide
    Jun Ma
    Chinese Journal of Integrative Medicine, 2007, 13 : 92 - 94
  • [43] Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia
    Lengfelder, E.
    Hofmann, W-K
    Nowak, D.
    LEUKEMIA, 2012, 26 (03) : 433 - 442
  • [44] Advances in Management of Acute Promyelocytic Leukemia with Arsenic Trioxide
    马军
    Chinese Journal of Integrative Medicine, 2007, (02) : 92 - 94
  • [45] Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia
    E Lengfelder
    W-K Hofmann
    D Nowak
    Leukemia, 2012, 26 : 433 - 442
  • [46] Arsenic trioxide in acute promyelocytic leukemia: potion not poison
    Powell, Bayard L.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (09) : 1317 - 1319
  • [47] Pharmacokinetics of arsenic species with relapsed or refractory acute promyelocytic leukemia (APL) treated with arsenic trioxide (ATO) in Japanese patients.
    Shigeno, K
    Kobayashi, M
    Sahara, N
    Nakamura, S
    Fujisawa, S
    Naito, K
    Shinjo, K
    Takeshita, A
    Ohno, R
    Kinoshita, K
    Shimoya, M
    Kaise, T
    Ohnishi, K
    BLOOD, 2005, 106 (11) : 185B - 185B
  • [48] Oral Arsenic Trioxide in Front Line Therapy for Acute Promyelocytic Leukemia. A Prospective Costa Rican Study
    Rodriguez, Mariela
    Rojas, Ronald
    Vargas, Alejandra
    Angel Rodriguez, Miguel
    Garcia, Claudia
    Esquivel, Juliana
    Gerardo Rojas, Jose
    Bujan Boza, Willem
    BLOOD, 2019, 134
  • [49] Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia
    Shigeno, K
    Nakamura, S
    Naito, K
    Yoshida, H
    Fujisawa, S
    Shinjo, K
    Fujita, Y
    Matsui, H
    Sahara, N
    Takeshita, A
    Ohno, R
    Ohnishi, K
    BLOOD, 2002, 100 (11) : 264B - 264B
  • [50] Bone Marrow Findings in Patients With Acute Promyelocytic Leukemia Treated With Arsenic Trioxide
    Miller, Karin P.
    Venkataraman, Girish
    Gocke, Christopher D.
    Batista, Denise A.
    Borowitz, Michael J.
    Burns, Kathleen H.
    Pratz, Keith
    Duffield, Amy S.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2019, 152 (05) : 675 - 685
12345